| Mrs Ashley Nicole Lowden, NP-C | |
|
101 Cherry St, Gadsden, AL 35901-5234 | |
| (877) 231-3376 | |
| (850) 522-8354 |
| Full Name | Mrs Ashley Nicole Lowden |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 101 Cherry St, Gadsden, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003583113 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1153118 (Alabama) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1-153118 (Alabama) | Primary |
| Entity Name | Southeastern Dermatology Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518972231 PECOS PAC ID: 9931277233 Enrollment ID: O20110628000133 |
News Archive
A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world's first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
A new test for urothelial cancers could detect mutations in DNA that have been identified for those cancers earlier than traditional tests. The earlier detection of urothelial cancer could lead to earlier treatment, and potentially better outcomes for patients.
Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ashley Nicole Lowden, NP-C 2505 Harrison Ave, Panama City, FL 32405-4464 Ph: (850) 233-3376 | Mrs Ashley Nicole Lowden, NP-C 101 Cherry St, Gadsden, AL 35901-5234 Ph: (877) 231-3376 |
News Archive
A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world's first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
A new test for urothelial cancers could detect mutations in DNA that have been identified for those cancers earlier than traditional tests. The earlier detection of urothelial cancer could lead to earlier treatment, and potentially better outcomes for patients.
Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.
› Verified 3 days ago